<DOC>
	<DOC>NCT00830167</DOC>
	<brief_summary>This study, will compare pregabalin with placebo for the duration of 15 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.</brief_summary>
	<brief_title>Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>ACR criteria for fibromyalgia A score of more or equal to 40 mm on the Pain VAS An average score more or equal to 4 on 4 daily pain diaries Patients with other severe pain conditions Patients with severe depression Patients taking excluded medications Patients with suicidality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>